The United States-based Leducq Foundation for Cardiovascular Research (LFCR) is a not-for-profit private foundation under the 501(c)(3) tax code.
Governance of the French Fondation Leducq is organized according to French law. A nine-member Board of Directors (Conseil d’Administration), led by the President of the foundation, is responsible for overall administration and oversight. A representative of the French Interior Ministry participates in the Board’s activities.
The scientific activities of the Leducq organization are guided by a fourteen-member Scientific Advisory Committee (SAC), composed of internationally recognized experts in cardiology, cardiac surgery, and neurovascular medicine from Europe and North America. The SAC is responsible for evaluating the scientific merit of all funding requests made to the foundation, and for monitoring the progress of those research programs ultimately selected for funding. According to the SAC charter, there shall be fourteen members on the SAC, seven of whom should be from North-America, and seven from Europe. The Presidency of the SAC is to rotate every three years between North American and European members.
The Officers of LFCR are:
- David Tancredi, M.D., Ph.D., President
- Martín Landaluce, Vice President
- James Floyd, Secretary
Board of Directors (Conseil d’Administration)
- Martín Landaluce, President
- Dr. David Tancredi, Executive Director & Treasurer
- Edouard Boscher
- Jean-Guy de Chalvron, Interior Ministry Representative
- Dr. Annabel Chen-Tournoux
- Maître Maylis Chevallier
- Laurent Deltour
- Clare Gaunt
- Patrick Laurens-Frings
- Claude Lauzanne, Secretary
Scientific Advisory Committee
North American members:
- Dr. Mark Anderson (Vice President), Johns Hopkins University School of Medicine, Baltimore, MD, USA
- Dr. Daniel Drucker, Lunenfeld Tanenbaum Research Institute, Toronto, Canada
- Dr. Donna Ferriero, University of California, San Francisco, CA, USA
- Dr. Daniel Rader, University of Pennsylvania, Philadelphia, PA, USA
- Dr. Todd Rosengart, Baylor College of Medicine, Houston, TX, USA
- Dr. Anthony Rosenzweig, Massachusetts General Hospital, Boston, MA, USA
European members:
- Dr. Barbara Casadei, University of Oxford, United Kingdom
- Dr. Elisabetta Dejana, University of Milan, Italy
- Dr. Ulrich Dirnagl, Charité-University of Medicine of Berlin, Germany
- Dr. Christian Hamm, Kerckhoff Heart Center, Bad Nauheim, Germany
- Dr. Göran Hansson (President), Karolinska Institute, Stockholm, Sweden
- Dr. Christine Mummery, Leiden University Medical Center, Netherlands
- Dr. Alain Tedgui, Paris-Cardiovascular Research Center, France
- Dr. Rudi Zechner, Institute of Molecular Biosciences, Karl Franzens Universität Graz, Austria